# How Should Companies Benchmark FRAND Rates for Standard-Essential Patents in 2026?

iprs.cloud · September 27, 2026

> Direct Answer to FRAND Rate Benchmarking FRAND rate benchmarking is the process of comparing a proposed license for a standard-essential patent, or...

## Direct Answer to FRAND Rate Benchmarking

FRAND rate benchmarking is the process of comparing a proposed license for a standard-essential patent, or SEP, with observable rates, valuation evidence, and litigation outcomes involving comparable patents, technologies, claim scope, and market conditions. It is not a search for one publicly posted “FRAND price.” FRAND generally means fair, reasonable, and nondiscriminatory, but the term does not produce an automatic royalty percentage or per-device rate. As of 28 September 2026, a defensible benchmark normally combines a bottom-up valuation, a top-down check, comparable licensing evidence, and a jurisdiction-specific legal analysis. A company should also distinguish an initial negotiation position from a rate it could defend before a court or regulator. A rate can be commercially aggressive and still be too high for FRAND purposes, while a conservative proposal can fail if it does not fairly account for the patentee’s legitimate portfolio contribution. Benchmarking should therefore support an evidence-based negotiating range, not merely justify a predetermined number. The core question is whether the evidence permits a reasoned conclusion that the proposed terms are both reasonable and nondiscriminatory across similarly situated licensees.

**Also worth reading:** [AI patent portfolio pruning playbook: how should companies systematically drop low-value AI patents in 2026?](https://iprs.cloud/knowledge/ai_patent_portfolio_pruning_playbook_how_should_companies_systematically_drop_low-value_ai_patents_in_2026.php) · [How Should Companies Value SEP Royalties Before Accepting, Auditing, or Challenging a FRAND License?](https://iprs.cloud/knowledge/how_should_companies_value_sep_royalties_before_accepting_auditing_or_challenging_a_frand_license.php) · [What Are the Most Effective SEP FRAND Defense Tactics for Companies Facing Patent Litigation in 2026?](https://iprs.cloud/knowledge/what_are_the_most_effective_sep_frand_defense_tactics_for_companies_facing_patent_litigation_in_2026.php)

## How FRAND Rate Benchmarking Actually Works

The most reliable method is triangulated. In a bottom-up analysis, analysts identify the asserted claims, technical features actually implemented, their relative contribution to standard compatibility, expected rate for each relevant product, and the value of the patented technology after substitutes and alternatives are considered. WIPO discussions of FRAND economics emphasize that valuation must account for the incremental benefit conferred by the patented feature rather than assigning the value of an entire compliant product to one component. A top-down analysis works in the opposite direction by estimating the value of using the standard and allocating part of that value to the SEP holder. Comparable licenses provide a third check, although differences in patent coverage, royalty-bearing sales, territorial reach, payment timing, and litigation risk can make apparently similar agreements poor comparables. Judicial decisions are also evidence, not automatic tariffs. The work product should record every adjustment made to a comparable and explain why a selected set is more probative than alternatives.

No single input should dominate without scrutiny. Portfolio size alone is weak because portfolio quality and technical contribution differ. A licensee’s total volume matters because it affects bargaining power and transaction cost, but it should not justify discriminatory treatment when similarly situated implementers are compared. A headline royalty rate can also mislead if it excludes patent-pool administration fees, minimum royalties, past sales, or applies only to a narrow set of components. Conversely, a low aggregate royalty may still be burdensome if the definition of net sales or the royalty base captures value unrelated to the patented invention. The strongest result is a range supported by several independent methods, with sensitivity testing for the assumptions that most affect the outcome.

## Building the Comparable-License Dataset

A useful dataset begins with a defined technology and claim universe rather than a broad collection of patent agreements. Analysts should separate comparable essential patents from non-SEP licenses, agreements involving the same portfolio but different standards, and licenses covering an implementation rather than a standard. Each record should identify the publication or licensing family, effective date, relevant technology, geographic scope, royalty base, exclusivity, grant-back rights, defensive-publication terms, minimum payment, audit provisions, and any known dispute. Rates should be normalized consistently: distinguish a percentage of list price from a percentage of net sales, and separate component value from total product value. Historical rates should then be adjusted cautiously for changes in component cost, market adoption, patent coverage, and remaining patent life.

The comparison set should be smaller and stronger rather than large and indiscriminate. WIPO’s work on valuation methods and the role of the FRAND undertaking illustrates why economic allocation must be connected to the commitment made to the standard-setting organization. An agreement may be publicly described as FRAND without disclosing enough detail to compare it with a proposed license. In that situation, the analyst should use the known terms but assign lower weight to undisclosed variables. Public court records, licensing announcements, competition-authority decisions, and adjudicated cases can supplement the dataset, but their facts must be matched before they are treated as comparables. The 40%+ figure reported in a 2026 LexisNexis-related account regarding PAE participation in recent US SEP cases, for example, is relevant to forum strategy, not directly to the correct royalty rate. Mixing litigation volume with valuation frequency would confuse two different datasets.

| Feature | Bottom-up valuation | Top-down allocation |
| --- | --- | --- |
| Starting point | Implemented claim features and their technical contribution | Economic value of access to the standard |
| Main question | What is the patented increment worth to the implementer? | How much of the standard’s value belongs to the patent owner? |
| Typical inputs | Claim scope, alternatives, component price, technical contribution, comparable component rates | Standard adoption, product margins, licensing expenditure, total portfolio economics |
| Common weakness | Requires technically reliable claim and contribution analysis | Aggregate value may be allocated too broadly or too narrowly |
| Best use | Anchoring negotiations for individual patents or portfolios | Sanity-checking a bottom-up result against the implementer’s economics |

## Choosing and Normalizing Rate Metrics
Rate normalization is where many private benchmarks become misleading. Analysts should distinguish percentages of net sales from per-unit amounts and from fixed annual minimums. They should also clarify whether a rate covers one patent, a patent family, a portfolio, a pool, or a combination license. The comparison should preserve distinctions among exclusive, sole, and nonexclusive rights, and should account for royalties paid to other essential patentees when assessing total licensing burden. A stated 3% rate on a product with a low net-sales margin is not economically equivalent to 3% on only the standard-relevant component. Similarly, a 3% rate applied to a large installed base may generate more revenue than a 5% rate limited to a small component, even though the latter appears more expensive on paper.

A practical worksheet should present the numerator, denominator, time period, and covered products in explicit terms. It should show whether rates are nominal or inflation-adjusted, whether retroactive payment is available, and whether confidentiality prevents exact peer comparison. The analyst can then calculate several outputs rather than rely on one metric: implied royalty per unit, aggregate portfolio burden, net present value, and a per-component value. Where the necessary inputs are unavailable, a range or scenario is preferable to false precision. The result should state its confidence level and identify the evidence that would change the conclusion. A benchmark that reports “the FRAND rate is 2.5%” without defining the royalty base or claim coverage is not decision-grade analysis.

## Technical, Legal, and Economic Variables That Matter

Technical comparability is central because FRAND attaches to an essential patent claim, not to the commercial importance of a brand or the mere existence of a standards declaration. Analysts should compare the asserted claim with the standard version, implementation profile, and relevant alternatives. If a feature is mandatory, easily designed around at low cost, or supplied by many competing vendors, that fact may reduce the appropriate allocation to the patentee. If the feature solves a difficult technical problem, is implemented uniformly, and is not easily replaced, its contribution may justify a larger share. These observations do not eliminate case-specific analysis, but they help connect the legal question about essentiality to the economic question about value.

Legal variables can change the result even when technical facts remain constant. The governing jurisdiction may treat comparables, cost contribution, or the patentee’s portfolio size differently, and the applicable law may have changed since an older agreement. Antitrust authorities and courts may also examine whether a license is nondiscriminatory, whether similarly situated licensees receive comparable treatment, and whether the terms remain consistent with the FRAND undertaking. The Munich Court’s effort to develop more efficient FRAND guidelines illustrates the procedural value of clear proposals, but procedural guidance is not itself a rate-setting formula. Restitution remains a contested doctrinal question, and WIPO and industry discussions continue to debate how damages, valuation, and judicial analysis interact. No benchmark should assume that a negotiated license automatically resolves an overcharge claim or future conduct dispute.

## Practical Steps for Counsel and Product Teams

Start by defining the decision and the covered assets. Counsel should identify the exact patent families, standards, product lines, countries, sales period, and requested license scope. Product teams should then document which claimed features appear in shipped products and which alternatives were available. With that foundation, the team can assemble a normalized comparable set and run at least two valuation approaches. The output should include a low, central, and high range, together with a written explanation of uncertainty. It should not collapse those cases into a single figure before negotiations begin. A negotiation range can be internally divided into opening, target, reservation, and litigation-exposure scenarios, but those labels should remain confidential and should not be presented to a counterparty as an admission.

The next step is to test the assumptions with opposing perspectives. A patentee may emphasize a broad portfolio, technical standardization, global reach, and the risk of future generations of products. An implementer may emphasize non-patent alternatives, prior licenses, prior art, small component value, and the total cost of all essential rights. A credible analysis gives both arguments enough evidence to be evaluated and explains why one was accepted or rejected. Before a rate meeting, counsel should prepare a short term sheet showing the exact denominator, payment timing, audit rights, and treatment of affiliates and contract manufacturers. If the parties disagree on a critical technical fact, obtain a focused expert view rather than relying on general product assumptions. Keep source data, calculations, and assumptions versioned so that a later audit or court filing can reproduce the result.

## When to Act, and When to Wait

A benchmark should be completed before major negotiations, rate demands, pool elections, or settlement conferences, not after positions have hardened. It is especially useful when a licensee receives a demand covering several patent families or when a patentee proposes a rate far above a carefully selected comparable set. The analysis is also appropriate before signing a long-term agreement because definitions of net sales, retroactivity, and audit rights can alter the effective price. Waiting may be sensible when the relevant product has not shipped, technical implementation is unsettled, or the patent portfolio is still changing. A premature benchmark can create false confidence if the asset set is incomplete.

Timing should reflect the cost of delay. Every quarter of delay can affect bargaining leverage, but indefinite delay can also increase uncertainty and allow a party to argue that the proposed terms reflect the most current information. For a company managing a portfolio with multiple jurisdictions, a two-stage process often works: first perform a rapid range assessment, then commission deeper technical and jurisdiction-specific work before committing to a position. A rapid assessment may take days or weeks depending on data access, while a litigation-grade study generally requires months. That distinction matters because a board summary and an evidentiary expert report have different standards. Teams should specify the intended use before commissioning work, and should avoid presenting an internal screening model as a judicial valuation.

## Cost, Pricing, and Expected Deliverables

There is no universally published market price for FRAND rate benchmarking. A lightweight internal screening exercise may cost little beyond analyst and engineer time, while a multi-jurisdictional study involving technical experts, licensing specialists, and economic experts can cost substantially more. Any precise dollar figure in this area would be misleading without knowing the number of patent families, product complexity, evidence volume, jurisdictions, and whether litigation-grade work is required. The more relevant pricing question is what the deliverable contains. A useful budget should cover data collection, comparable normalization, technical mapping, economic modeling, sensitivity analysis, legal issue spotting, source documentation, and a management presentation. Expert reports may be priced separately from ordinary legal advice, and litigation support can require ongoing updates as new comparables emerge.

Buyers should be skeptical of providers offering a single universal rate, especially one based only on patent counts or an unexplained average of public licenses. A credible proposal should permit a sample scope, identify assumptions, and explain how confidential data will be handled. Deliverables should include a comparable table, calculation workbook or reproducible model, technical assumptions, sensitivity cases, limitations, and a concise negotiation summary. For iprs.cloud’s B2B context, the practical value is not in advertising a magic rate; it is in giving counsel and product teams a controlled way to organize evidence, registry records, portfolio data, and decision-ready ranges. Any platform recommendation should be assessed on auditability, permissioning, update controls, and export quality rather than on the promise of automatically determining FRAND compliance.

## Common Mistakes and the Final Decision Test

The most common mistake is treating a license offer, a pool rate, or a court award as a universal market price. Others include comparing rates with different royalty bases, ignoring the cost of other essential patents, using expired or challenged claims as if they were current, and assuming that a larger portfolio automatically deserves a proportionally larger rate. Analysts may also overvalue technical declarations without checking whether the asserted claim covers the implemented feature. On the opposite side, a licensee can make an equally weak case by using the lowest available rate while ignoring patent quality, contribution, or the value of reliable access to the standard. Privacy restrictions do not justify removing all analysis; they require clearly labeled evidence gaps and scenario analysis.

Before accepting a proposed rate, ask five connected questions. First, what exact assets and products does the rate cover? Second, what evidence supports the allocation, and how does it change under reasonable alternatives? Third, do the comparables match on technology, scope, geography, and economic conditions? Fourth, is the rate consistent with the FRAND commitment and the applicable legal framework? Fifth, can the calculation be explained without relying on confidential assumptions that cannot be tested? If the answer to any question is no, the figure should remain a negotiating hypothesis rather than a conclusion. The best FRAND rate benchmark is consequently the one that is reproducible, transparent about uncertainty, sensitive to real differences, and capable of surviving scrutiny from both sides of the table.

## Quick answers

### Is there a single standard FRAND royalty rate for SEPs?

No. FRAND is a legal and economic standard, not a fixed percentage. The appropriate result depends on the patent, technology, product economics, portfolio contribution, comparable licenses, jurisdiction, and evidence available at the time.

### Should FRAND benchmarking use patent-pool rates?

They can be useful comparables when the technology, coverage, royalty base, and license scope are sufficiently similar. They should not be copied mechanically, because pool administration structures and bundled rights can differ from bilateral SEP licenses.

### How many comparables are enough for a useful FRAND study?

There is no required count. A smaller set of technically and economically close agreements may be more useful than dozens of loosely related licenses. The study should explain relevance, normalize differences, and disclose gaps.

### Does a court-selected rate settle future SEP licensing?

Not automatically. A judgment may inform valuation and negotiation, but it remains subject to its factual findings, legal scope, and subsequent changes in products, patent coverage, or market conditions. A future license still requires its own analysis.

### Can an implementer benchmark a rate without paying for a full expert study?

Yes, for internal screening, if the available product, patent, and licensing data are adequate. The result should be labeled preliminary and should be upgraded before major commitments or litigation, particularly where technical contribution is disputed.

Canonical: https://iprs.cloud/knowledge/how_should_companies_benchmark_frand_rates_for_standard-essential_patents_in_2026.php
Markdown: https://iprs.cloud/knowledge/how_should_companies_benchmark_frand_rates_for_standard-essential_patents_in_2026.php/index.md